490 related articles for article (PubMed ID: 19609919)
41. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
[TBL] [Abstract][Full Text] [Related]
42. [Copper in the feces--a marker for the effectiveness of zinc in the treatment of Wilson's disease].
Dastych M
Z Gastroenterol; 1990 Aug; 28(8):389-91. PubMed ID: 2275259
[TBL] [Abstract][Full Text] [Related]
43. Central pontine signal changes in Wilson's disease: distinct MRI morphology and sequential changes with de-coppering therapy.
Sinha S; Taly AB; Ravishankar S; Prashanth LK; Vasudev MK
J Neuroimaging; 2007 Oct; 17(4):286-91. PubMed ID: 17894614
[TBL] [Abstract][Full Text] [Related]
44. [EEG changes under sodium diethyldithiocarbamate therapy in 2 cases of Wilson's disease].
Lang HD; Reichenmiller HE; Tigges FJ; Braun HJ; Golisch G
Med Klin; 1972 Jun; 67(26):916-21. PubMed ID: 5048687
[No Abstract] [Full Text] [Related]
45. Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy.
Brewer GJ; Johnson VD; Dick RD; Hedera P; Fink JK; Kluin KJ
Hepatology; 2000 Feb; 31(2):364-70. PubMed ID: 10655259
[TBL] [Abstract][Full Text] [Related]
46. Anticopper efficacy of captopril and sodium dimercaptosulphonate in patients with Wilson's disease.
Wang XP; Yang RM; Ren MS; Sun BM
Funct Neurol; 2003; 18(3):149-53. PubMed ID: 14703896
[TBL] [Abstract][Full Text] [Related]
47. [Values of serum copper and serum free copper in the diagnosis and monitoring of Wilson's disease and its carriers].
Zhou XX; Li XH; Huang HW; Liu B; Zhu RL; Liang YY; Zhu JZ; Liang XL
Zhonghua Yi Xue Za Zhi; 2011 Oct; 91(39):2757-60. PubMed ID: 22322054
[TBL] [Abstract][Full Text] [Related]
48. Wilson's disease: clinical management and therapy.
Brewer GJ; Askari FK
J Hepatol; 2005; 42 Suppl(1):S13-21. PubMed ID: 15777568
[No Abstract] [Full Text] [Related]
49. Reply to T.U. Hoogenraad's paper published last April. Zinc therapy in Wilson's disease.
Marcellini M; Sartorelli MR; Nobili V
Brain Dev; 2007 Jan; 29(1):55. PubMed ID: 16904856
[No Abstract] [Full Text] [Related]
50. Molecular genetics and zinc-copper interactions in human Wilson's disease and canine copper toxicosis.
Brewer GJ; Yuzbasiyan-Gurkan V; Lee DY
Prog Clin Biol Res; 1993; 380():129-45. PubMed ID: 8456122
[No Abstract] [Full Text] [Related]
51. Chronic axonal-demyelinating polyradicular neuropathy associated with mycosis fungoides: a case report.
Cardinali P; Serrao M; Rossi P; De Dominicis L; Logullo F; De Santis F; Pierelli F
Neurol Sci; 2005 Dec; 26(5):344-8. PubMed ID: 16388370
[TBL] [Abstract][Full Text] [Related]
52. [Liver pathology in Wilson's disease].
Valmary J; Ricordel I; Mazière B; Vergeau B; Fléchaire A; Algayres JP; Daly JP; Laverdant C
Ann Gastroenterol Hepatol (Paris); 1988; 24(4):197-203. PubMed ID: 3048201
[No Abstract] [Full Text] [Related]
53. Work ability assessment in a patient with Wilson's disease.
Popević MB; Kisić G; Dukić M; Bulat P
Arh Hig Rada Toksikol; 2011 Jun; 62(2):163-7. PubMed ID: 21705304
[TBL] [Abstract][Full Text] [Related]
54. [A case of neurologic type of Wilson's disease with increased aluminum in liver: comparative study with histological findings to metal contents in the liver].
Yasui M; Kohmoto J; Ota K; Shinmen K; Tanaka H; Nogami H
No To Shinkei; 1998 Aug; 50(8):767-72. PubMed ID: 9757472
[TBL] [Abstract][Full Text] [Related]
55. Liver transplantation in Wilson's disease: are its indications established?
Marin C; Robles R; Parrilla G; Ramírez P; Bueno FS; Parrilla P
Transplant Proc; 2007 Sep; 39(7):2300-1. PubMed ID: 17889170
[TBL] [Abstract][Full Text] [Related]
56. Wilson's disease tremor is associated with magnetic resonance imaging lesions in basal ganglia structures.
Südmeyer M; Saleh A; Wojtecki L; Cohnen M; Gross J; Ploner M; Hefter H; Timmermann L; Schnitzler A
Mov Disord; 2006 Dec; 21(12):2134-9. PubMed ID: 17044091
[TBL] [Abstract][Full Text] [Related]
57. Motor neuron disease associated with copper deficiency.
Weihl CC; Lopate G
Muscle Nerve; 2006 Dec; 34(6):789-93. PubMed ID: 16929546
[TBL] [Abstract][Full Text] [Related]
58. [Acquired copper deficiency myelopathy].
Videt-Gibou D; Belliard S; Rivalan J; Ménard D; Edan G
Rev Neurol (Paris); 2010; 166(6-7):639-43. PubMed ID: 20466396
[TBL] [Abstract][Full Text] [Related]
59. Acute painful neuropathy in thallium poisoning.
Kuo HC; Huang CC; Tsai YT; Chu CC; Hsieh ST; Chu NS
Neurology; 2005 Jul; 65(2):302-4. PubMed ID: 16043805
[TBL] [Abstract][Full Text] [Related]
60. Clinical, physiological and pathological characterisation of the sensory predominant peripheral neuropathy in copper deficiency.
Taylor SW; Laughlin RS; Kumar N; Goodman B; Klein CJ; Dyck PJ; Dyck PJB
J Neurol Neurosurg Psychiatry; 2017 Oct; 88(10):839-845. PubMed ID: 28780535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
